Cisplatin Triggers Platelet Activation

Levine, 1988, The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer, N Engl J Med, 318, 404, 10.1056/NEJM198802183180703 Içli, 1993, Severe vascular toxicity associated with cisplatin-based chemoterapy, Cancer, 72, 587, 10.1002/1097-0142(19930715)72:2<587::AID-CNCR2820720242>3.0.CO;2-V Molloy, 1995, Arterial thrombosis after chemotherapy with cisplatin, vinblastine and methotrexate, Br J Clin Prat, 49, 50 Lepidini, 1996, Severe thrombosis after chemotherapy for metastatic choriocarcinoma of the testis maintaining complete remission for a long period, Scand J Urol Nephrol, 31, 221, 10.3109/00365599709070337 Jackson, 1984, Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy, Ann Internal Med, 101, 41, 10.7326/0003-4819-101-1-41 Fields, 1989, Thrombotic microangiopathy associated with chemotherapy, DICP Ann Pharmacotherapy, 23, 582 Blanche, 1995, Microangiopathie thrombotique après chimio-embolisation par cisplatine (letter), Ann Med Intern, 146, 452 Kukla, 1982, Acute vascular episodes associated with therapy for carcinomas of the upper aerodigestive tract with bleomycin, vincristine and cisplatin, Cancer Treat Rep, 66, 369 Gerl, 1991, Acute cerebrovascular event after cisplatin-based chemotherapy for testicular cancer, Lancet, 338, 385, 10.1016/0140-6736(91)90521-P Vogelzang, 1985, Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin, Cancer, 56, 2765, 10.1002/1097-0142(19851215)56:12<2765::AID-CNCR2820561208>3.0.CO;2-2 Nicolson, 1985, Effects of chemotherapeutic drug on platelet and metastatic tumor cell–endothelial cell interactions as a model for assessing vascular endothelial integrity, Cancer Research, 45, 331 Doll, 1986, Vascular toxicity associated with antineoplastic agents, J Clin Oncol, 4, 1405, 10.1200/JCO.1986.4.9.1405 Schilsky, 1979, Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin, Ann Intern Med, 90, 929, 10.7326/0003-4819-90-6-929 Aitokallio-Tallberg, 1989, Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy, Br J Cancer, 60, 785, 10.1038/bjc.1989.360 Blöchl-Daum, 1995, Effects of cisplatin on urinary thromboxane B2 excretion, Clin Pharmacol Ther, 58, 418, 10.1016/0009-9236(95)90055-1 van Genderen, 1999, Thromboxane-dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia, Br J Haematol, 104, 438, 10.1046/j.1365-2141.1999.01224.x Born, 1962, Aggregation of blood platelets adenosine diphosphatase and its reversal, Nature (London), 194, 927, 10.1038/194927b0 Caprino, 1982, In vitro activity of urokinase on platelet function and on ADP-degradation by vascular tissue, Thromb Res, 27, 447, 10.1016/0049-3848(82)90062-7 Pignatelli, 1998, Hydrogen peroxide is involved in collagen-induced platelet activation, Blood, 91, 484, 10.1182/blood.V91.2.484 Kubisz, 1983, Influence of cis-platinum on some platelet functions in vitro, Neoplasma, 30, 391 Karolak, 1993, High-dose chemotherapy-induced platelet defect, Mol Pharmacol, 43, 37 Wachowicz, 1995, Changes of platelet cytoskeleton induced by cisplatin in relation to platelet activation, Biomed Lett, 52, 181 Olas, 1996, Cisplatin-induced changes in biological activity of blood platelets, Anti-cancer Drug, 7, 476, 10.1097/00001813-199606000-00013 Wachowicz, 1993, Inhibitory effect of cisplatin on the enzymatic peroxidation of platelet endogenous arachidonate, Cytobios, 75, 157 Softeland, 1992, Porcine platelets in vitro and in vivo studies, Eur J Haematol, 49, 161, 10.1111/j.1600-0609.1992.tb00043.x Poole, 1996, The study of platelet function in other species, 341 Hofmann, 1982, The effects of mepacrine and p-bromophenacyl bromide on arachidonic acid release in human platelets, Arch Biochem Biophys, 215, 237, 10.1016/0003-9861(82)90300-9 Hashizume, 1994, Arachidonic acid liberation induced by phosphatidic acid endogenously generated from membrane phospholipids in rabbit platelets, Biochim Biophys Acta, 1221, 179, 10.1016/0167-4889(94)90011-6 Wooten, 1999, Separation of integrin-dependent adhesion from morphological changes based on differential PLC specificities, J Leukoc Biol, 65, 127, 10.1002/jlb.65.1.127 Iorio, 1996, Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets, FEBS Letters, 381, 244, 10.1016/0014-5793(96)00117-2 Sadzuka, 1992, Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation, Biochem Pharmacol, 43, 1872, 10.1016/0006-2952(92)90725-X Matsushima, 1998, The role of oxygen free radical in cisplatin-induced acute renal failure in rats, J Lab Clin Med, 131, 518, 10.1016/S0022-2143(98)90060-9 Olas, 1998, Modulation of cisplatin toxicity in blood platelets by glutathione depletion, Anti-cancer Drug, 9, 473, 10.1097/00001813-199806000-00015 Tsutsumishita, 1998, Involvement of H2O2 production in cisplatin-induced nephrotoxicity, Biochem Biophys Res Commun, 242, 310, 10.1006/bbrc.1997.7962 Rashba-Step, 1997, Phospholipase peroxidation induces cytosolic phospholipase A2 activity, Arch Biochem Biophys, 343, 44, 10.1006/abbi.1997.0134 Schiess, 1992, Mobilization of diacylglycerol in intact HeLa cells by exogenous phospholipase C from Cl. Perfringens is accompanied by release of fatty acids including arachidonic acid, Biochim Biophys Acta, 1137, 82, 10.1016/0167-4889(92)90104-J Nishio, 1992, Phospholipase C-mediated hydrolysis of phosphatidylcholine is activated by cis-diamminedichloroplatinum (II), J Clin Invest, 89, 1622, 10.1172/JCI115758 DeConti, 1973, Clinical and pharmacological studies with cis-diamminedichloroplatinum (II), Cancer Res, 33, 1310